| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2015 | Development of a standardized and effect-optimized herbal extract of Wedelia chinensis for prostate cancer | Tsai, CH; Tzeng, SF; Hsieh, SC; Lin, CY; Tsai, CJ; Chen, YR ; Yang, YC; Chou, YW; Lee, MT; Hsiao, PW | PHYTOMEDICINE 22, 406 | | | |
| 2017 | Granulysin expressed in a humanized mouse model induces apoptotic cell death and suppresses tumorigenicity | Hsiao, YW; Lai, TC; Lin, YH; Su, CY; Liao, AT; Lin, YF; Hsieh, SC; Wu, AT; Hsiao, M | Oncotarget [Epub ahead of print] | | | |
| 2009 | Herbal Extract of Wedelia chinensis Attenuates Androgen Receptor Activity and Orthotopic Growth of Prostate Cancer in Nude Mice | Tsai, CH; Lin, FM; Yang, YC; Lee, MT ; Cha, TL; Wu, GJ; Hsieh, SC; Hsiao, PW | Clinical Cancer Research 15(17), 5435-5444 | | | |
| 2015 | Rapid identification of Mycobacterium avium clinical isolates by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. | Lin, CS; Su, CC; Hsieh, SC; Lu, CC; Wu, TL; Jia, JH; Wu, TS; Han, CC; Tsai, WC; Lu, JJ; Lai, HC | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 48(2), 205-12 | | | |
| 2013 | Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke. | Yu, YL; Chou, RH; Shyu, WC; Hsieh, SC; Wu, CS; Chiang, SY; Chang, WJ; Chen, JN; Tseng, YJ; Lin, YH; Lee, W; Yeh, SP; Hsu, JL; Yang, CC; Hung, SC; Hung, MC | EMBO molecular medicine 5(4), 531-47 | | | |
| 2015 | Standardized extract of Wedelia chinensis for prostate cancer treatment by targeting intrinsic survival pathways and immunomodulation | Tsai, CH; Tzeng, SF; Hsieh, SC; Lin, CY; Tsai, CJ; Yang, YC; Hsiao, JH; Tsai, MH; Lee, MT; Hsiao, PW | Phytomedicine 22(3): 406-414 | | | |
| 2009 | The prognostic values of soft tissue sonography for adult cellulitis without pus or abscess formation. | Huang, MN; Chang, YC; Wu, CH; Hsieh, SC; Yu, CL | Internal medicine journal 39(12), 841-4 | | | |
| 2015 | Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study | Ko, TM ; Tsai, CY; Chen, SY; Chen, KS; Yu, KH; Chu, CS; Huang, CM; Wang, CR; Weng, CT; Yu, CL; Hsieh, SC; Tsai, JC; Lai, WT; Tsai, WC; Yin, GD; Ou, TT; Cheng, KH; Yen, JH; Liou, TL; Lin, TH; Chen, DY; Hsiao, PJ; Weng, MY; Chen, YM; Chen, CH; Liu, MF; Yen, HW; Lee, JJ; Kuo, MC; Wu, CC; Hung, SY; Luo, SF; Yang, YH; Chuang, HP; Chou, YC; Liao, HT; Wang, CW; Huang, CL; Chang, CS; Lee, MT ; Chen, P; Wong, CS; Chen, CH ; Wu, JY ; Chen, YT ; Shen, CY ; Taiwan Allopurinol-SCAR Consortium | BMJ-British Medical Journal 351, h4848 | | | |
